Vitenskapelig artikkel

• Baard-Christian Schem; Frank Pfeffer; Martin Anton Ott et al. (2022). Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas. (ekstern lenke)
• Peer Kåre Lilleng; Odd R Monge; Anders Walløe et al. (1997). Fibrosarcoma in children. (ekstern lenke)
• Mette Pernille Myklebust; Zhiping Li; Thai H. Tran et al. (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. (ekstern lenke)
• Jens Overgaard; Maarten CCM Hulshof; Olav Dahl et al. (2024). ESHO 1–85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic Oncology. (ekstern lenke)
• Kjetil Boye Pedersen; Havjin Jacob; Kari-Anne Frikstad et al. (2016). Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. (ekstern lenke)
• K Theodrou; K Platoni; D Lefkopoulos et al. (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isocentric techniques. (ekstern lenke)
• Lars Fredrik Fjæra; Zuofeng Li; Kristian Ytre-Hauge et al. (2017). Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. (ekstern lenke)
• Kjersti Elvestad Hestetun; Nina Benedikte Rosenlund; Luka Stanisavljevic et al. (2022). Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer. (ekstern lenke)
• Torgrim Tandstad; Olof Ståhl; Olav Dahl et al. (2016). Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). (ekstern lenke)
• K. Theodrou; K. Platoni; D. Lefkopoulos et al. (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isosentric techniques. (ekstern lenke)
• M Brydøy; Sophie Dorothea Fosså; Olbjørn Klepp et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• Havjin Jacob; Luka Stanisavljevic; Kristian Eeg Storli et al. (2018). A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. (ekstern lenke)
• L Balteskard; Barthold Vonen; Gunilla Frykholm et al. (2007). Strålebehandling av endetarmskreft. (ekstern lenke)
• Ludvig Paul Muren; Anthony Thomas Redpath; Duncan McLaren et al. (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. (ekstern lenke)
• Helgi Kjartan Sigurdsson; Hartwig Kørner; Olav Dahl et al. (2009). Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. (ekstern lenke)
• Jørgen Gitlesen Krohn; Torbjørn Frøystein; Olav Dahl (2008). Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus. (ekstern lenke)
• Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp et al. (2010). Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. (ekstern lenke)
• Jon Espen Dale; Silvia Molinelli; Barbara Vischioni et al. (2020). Brainstem NTCP and dose constraints for carbon ion RT—Application and translation from Japanese to European RBE-weighted dose. (ekstern lenke)
• Olav Dahl; Øystein Fluge; Erik Carlsen et al. (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. (ekstern lenke)
• Carina Nord; Trine Bjøro; Dag Ellingsen et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Kathrine Røe; Ludvig Muren; Jarle Rørvik et al. (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. (ekstern lenke)
• Øystein Fluge; K Gravdal; E Carlsen et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (ekstern lenke)
• Marianne Brydøy; Anette Margrethe Storstein; Olav Dahl (2007). Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma. (ekstern lenke)
• Bengt Glimelius; Olav Dahl; Björn Cedermark et al. (2005). Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• D Ellingsen; Arnstein Mykletun; O Dahl et al. (2003). Gonadal hormones in longterm survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Halfdan Sørbye; Bengt Glimelius; Å Berglund et al. (2004). Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. (ekstern lenke)
• Olav Dahl; Ronny Dalene; Baard Christian Schem et al. (1999). Status of clinical hyperthermia. (ekstern lenke)
• Hege Sagstuen Haugnes; Niels Christian Stenklev; Marianne Brydøy et al. (2018). Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. (ekstern lenke)
• Hege Sagstuen Haugnes; Torgeir Wethal; Nina Kathrine Aass et al. (2010). Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. (ekstern lenke)
• Jørgen Gitlesen Krohn; Torbjørn Frøystein; Olav Dahl (2009). Topographical distribution of choroidal naevi in the ocular fundus. (ekstern lenke)
• O Klepp; Olav Dahl; P Flodgren et al. (1997). for the Swedish-Norwegian Testis Cancer Group (SWENOTECA). (ekstern lenke)
• Magnus Berle; Kjersti Elvestad Hestetun; Heidrun Vethe et al. (2022). Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature. (ekstern lenke)
• Ludvig Muren; Olav Mella; Rune Hafslund et al. (2002). Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy. (ekstern lenke)
• Nils Hovdenak; Halfdan Sørbye; Olav Dahl (2005). SSucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis. (ekstern lenke)
• Hans Petter Eikesdal; Oddbjørn Straume; Lars A. Akslen et al. (2004). Karnydanning og tumorkar som mål for kreftterapi. (ekstern lenke)
• Mette Pernille Myklebust; Ove Bruland; Øystein Fluge et al. (2011). MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. (ekstern lenke)
• Ingrid Gurvin Rekeland; Kari Sørland; Ove Bruland et al. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. (ekstern lenke)
• Yngve Kvinnsland; Ludvig Paul Muren; Olav Dahl (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter. (ekstern lenke)
• Sven-Erik Olofsson; Torgrim Tandstad; Mats Jerkeman et al. (2011). Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian testicular cancer group. (ekstern lenke)
• KJERSTI BRUHEIM; Marianne Guren; Eva Skovlund et al. (2010). Late side effects and quality of life after radiotherapy for rectal cancer. (ekstern lenke)
• Jon Espen Dale; Sigrunn Sebjørnsen; Sabine Maria Leh et al. (2016). Multimodal therapy is feasible in elderly anal cancer patients. (ekstern lenke)
• Jørgen Gitlesen Krohn; Olav Dahl (2008). Incidence of iris melanoma in western Norway. (ekstern lenke)
• M Baumann; J.W.H. Leer; Olav Dahl et al. (2004). Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe. (ekstern lenke)
• Dirk Rades; Cornelia Setter; Jürgen Dunst et al. (2010). Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC). (ekstern lenke)
• Olav Dahl; Jon Espen Dale; Marianne Brydøy (2018). Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment. (ekstern lenke)
• Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• Sissel Elisabeth Dyrstad; Maria Lie Lotsberg; Tuan Zea Tan et al. (2021). Blocking aerobic glycolysis by targeting pyruvate dehydrogenase kinase in combination with EGFR TKI and ionizing radiation increases therapeutic effect in non-small cell lung cancer cells. (ekstern lenke)
• Kjersti Elvestad Hestetun; Marianne Brydøy; Mette Pernille Myklebust et al. (2015). Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. (ekstern lenke)
• Alv A Dahl; Carl Fredrik Haaland; Anstein Mykletun et al. (2005). Study of anxiety disorder and depression in long-term survivors of testicular cancer. (ekstern lenke)
• Marianne Guren; Hartwig Kørner; Frank Pfeffer et al. (2015). Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. (ekstern lenke)
• Erling Dahl Borkamo; Olav Dahl; Ove Bruland et al. (2008). Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. (ekstern lenke)
• T Skaali; Sophie Dorothea Fosså; R Bremnes et al. (2008). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen Haugnes; Nina Aass; SD Fosså et al. (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. (ekstern lenke)
• S Knutsen; Rune Hafslund; Odd R Monge et al. (2001). Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. (ekstern lenke)
• Annette Larsen; Igor B. Bronstein; Olav Dahl et al. (2007). Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. (ekstern lenke)
• Olav Dahl (2007). Adjuvant kjemoterapi ved tykktarmskreft. (ekstern lenke)
• Olav Dahl; Mette Pernille Myklebust (2024). A study of microRNAs as new prognostic biomarkers in anal cancer patients. (ekstern lenke)
• Luka Stanisavljevic; Mette Pernille Myklebust; Sabine Maria Leh et al. (2016). LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. (ekstern lenke)
• Øystein Fluge; Olav Mella; Ove Bruland et al. (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. (ekstern lenke)
• Wenche Kristiansen; Kristine Engen Andreassen; Robert Karlsson et al. (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. (ekstern lenke)
• IJ Orre; Sophie Dorothea Fosså; SD Fossa et al. (2008). Chronic cancer-related fatigue in long-term survivors of testicular cancer. (ekstern lenke)
• Torgrim Tandstad; Arne Solberg; Ulf Håkansson et al. (2014). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. (ekstern lenke)
• Lene Thorsen; Wenche Nystad; Olav Dahl et al. (2003). The level of physical activity in long-term survivors of testicular cancer. (ekstern lenke)
• Adam J Bass; Hideo Watanabe; Craig Mermel et al. (2009). SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. (ekstern lenke)
• Magne Kjell Tveit; Tormod Kyrre Guren; Bengt Glimelius et al. (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. (ekstern lenke)
• Mette Pernille Myklebust; Nina Benedikte Rosenlund; Peder Gjengstø et al. (2019). Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis. (ekstern lenke)
• Marianne Brydøy; Sophie D. Fosså; Olbjørn Klepp et al. (2005). Paternity Following Treatment for Testicular Cancer. (ekstern lenke)
• Erling Dahl Borkamo; Baard-Christian Schem; Øystein Fluge et al. (2009). cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. (ekstern lenke)
• Jon Espen Dale; Silvia Molinelli; Elisa Ciurlia et al. (2017). Risk of carotid blowout after reirradiation with particle therapy. (ekstern lenke)
• Lene Thorsen; Wenche Nystad; Hein Stigum et al. (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorders in long-term survivors of testicular cancer and men in the general population sample. (ekstern lenke)
• Mette Pernille Myklebust; Anne Mette Søviknes; Ole Johan Halvorsen et al. (2022). MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer. (ekstern lenke)
• Nils Hovdenak; Åsa Karlsdottir; Halfdan Sørbye et al. (2003). Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. (ekstern lenke)
• Hans Petter Eikesdal; Rolf Bjerkvig; James A. Raleigh et al. (2001). Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia. (ekstern lenke)
• Kjersti Elvestad Hestetun; Kristine Aasebø; Nina Benedikte Rosenlund et al. (2020). Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer. (ekstern lenke)
• Anne Gry Bentzen; Lise Balteskard; Eva Hoff Wanderås et al. (2013). Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. (ekstern lenke)
• Hans Petter Eikesdal; Willy Landuyt; Olav Dahl (2002). The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas. (ekstern lenke)
• Inger Norderhaug; Truls Bjerklund Johansen; Olav Dahl et al. (2002). Brakyterapi ved prostatakreft. (ekstern lenke)
• Ludvig Muren; Nina Jebsen; Anders Gustafsson et al. (2001). Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters. (ekstern lenke)
• Kristine Engen Andreassen; Wenche Kristiansen; Robert Karlsson et al. (2013). Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. (ekstern lenke)
• Alv A Dahl; Roy M. Bremnes; Olav Dahl et al. (2007). Is the sexual function compromised in long-term testicular cancer survivors?. (ekstern lenke)
• M Brydoy; Marianne Brydøy; Sophie D. Fosså et al. (2007). Gonadal dysfunction and fertility problems in cancer survivors. (ekstern lenke)
• B Ly; NO Solum; AM Vennerød et al. (1978). A syndrome of factor VVI deficiency and abnormal platelet release reaction. (ekstern lenke)
• Hege Sagstuen Haugnes; Anna Laurell; Ulrika Stierner et al. (2012). High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). (ekstern lenke)
• Annette Larsen; Nils Hovdenak; Åsa Karlsdottir et al. (2004). Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. (ekstern lenke)
• Sunniva Todnem Sakkestad; Bjørn Christian Elias Grova Olsen; Anne Karliczek et al. (2015). Validity of Norwegian Rectal Cancer Registry data at a major university hospital 1997-2005. (ekstern lenke)
• Marianne Brydøy; Sophie Dorothea Fosså; Olbjørn Klepp et al. (2012). Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. (ekstern lenke)
• Ludvig Muren; Rune Hafslund; Harald Valen et al. (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. (ekstern lenke)
• Jørgen Gitlesen Krohn; Olav Dahl; Tone Nybø et al. (2014). Brachytherapy for malignant uveal melanoma. (ekstern lenke)
• Johannes Jernqvist Gaare; Gonzalo Sanchez Nido; Pawel Szymon Sztromwasser et al. (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. (ekstern lenke)
• Hege Sagstuen; Nina Kathrine Aass; Sophie Dorothea Fosså et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Otilia Leon; Marianne Guren; Oskar Hagberg et al. (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. (ekstern lenke)
• A Mykletun; Alv A Dahl; Carl Fredrik Haaland et al. (2005). Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. (ekstern lenke)
• Sophie D. Fosså; N. Aass; K. Tveter et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Helgi Kjartan Sigurdsson; Hartwig Kørner; Olav Dahl et al. (2007). Clinical characteristics and outcomes in patients with advanced rectal cancer: A national prospective cohort study. (ekstern lenke)
• M Brydoy; SD Fossa; Olbjørn Klepp et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• O. Klepp; O Dahl; P Flodgren et al. (1997). Risk-adapted treatment of clinical stage I non-seminaoma testis cancer. (ekstern lenke)
• Christian Ekanger; Svein Inge Helle; Daniel Heinrich et al. (2020). Ten-year results from a phase II study on image guided, Intensity Modulated Radiation Therapy with simultaneous integrated boost in high-risk prostate cancer. (ekstern lenke)
• Annette Larsen; Benedikte Bjørge; Beate Klementsen et al. (2007). Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. (ekstern lenke)
• Erling Dahl Borkamo; Øystein Fluge; Olav Mella et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (ekstern lenke)
• Havjin Jacob; Luka Stanisavljevic; Kristian Eg Storli et al. (2017). Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. (ekstern lenke)
• Marianne Guren; Bjarte Aagnes; Mari Nygård et al. (2018). Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. (ekstern lenke)
• Ove Bruland; Øystein Fluge; Heike Immervoll et al. (2008). Gene expression reveals two distinct groups of anal carcinomas with clinical implications. (ekstern lenke)
• Helgi Kjartan Sigurdsson; Hartwig Kørner; Olav Dahl et al. (2008). Palliative surgery for rectal cancer in a national cohort. (ekstern lenke)
• Ludvig Paul Muren; Ása Karlsdóttir; Tore Wentzel-Larsen et al. (2005). Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum. (ekstern lenke)
• Ludvig Muren; Rune Småland; Olav Dahl (2003). Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. (ekstern lenke)
• Yngve Kvinnsland; Ludvig Paul Muren; Olav Dahl (2004). Evaluation of a new method for calculation of cumulative doses in the rectum wall using repeat CT scans. (ekstern lenke)
• Torgrim Tandstad; Rune Smaaland; Arne Solberg et al. (2011). Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. (ekstern lenke)
• Rune Kvåle; Bjørn Møller; Anders Angelsen et al. (2010). Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. (ekstern lenke)
• Per Øgreid; AA Berner; Olav Dahl et al. (1999). Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. (ekstern lenke)
• PK Lilleng; OR Monge; A Walløe et al. (1997). Fibrosarcoma in children. A rare tumour with long-term survival even with advanced disease. A report of 3 cases. (ekstern lenke)
• Halfdan Sørbye; Olav Dahl (2003). Nordic 5-Fluorouracil/Leucovorin bolus schedule combined with Oxaliplatin (Nordic FLOX)as first-line treatment of metastatic colorectal cancer. (ekstern lenke)
• AJ Terzis; Frode Thorsen; O Heese et al. (1997). Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. (ekstern lenke)
• Hans Petter Eikesdal; Steinar T. Bjørkhaug; Olav Dahl (2002). Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat. (ekstern lenke)
• Kåre Bakkevold; Bo Arnesjø; Olav Dahl et al. (1993). Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater - Results of a controlled, prospective, randomised multicentre study. (ekstern lenke)
• Ludvig Muren; Rune Hafslund; Anders Gustafsson et al. (2001). Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. (ekstern lenke)
• Hans Petter Eikesdal; Rolf Bjerkvig; Olav Mella et al. (2001). Combretastatin A-4 and hyperthermia; a potent combination for the treatment of solid tumors. (ekstern lenke)
• Dirk Rades; Cornelia Setter; Olav Dahl et al. (2011). Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. (ekstern lenke)
• Olav Dahl; Erling Dahl Borkamo; Øystein Fluge (2008). Current status of antivascular therapy and targeted treatment in the clinic. (ekstern lenke)
• Kathrine Røe; Ludvig Paul Muren; Jarle Rørvik et al. (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. (ekstern lenke)
• hege Sagstuen; N Aass; SD Fossa et al. (2007). Components of the metabolic syndrome in long-term survivors of testicular cancer. (ekstern lenke)
• Zhiping Li; Xuanmao Jiao; Chenguang Wang et al. (2010). Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response. (ekstern lenke)
• Erling Dahl Borkamo; Olav Dahl; Ove Bruland et al. (2009). Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. (ekstern lenke)
• Åsa Karlsdottir; Dag Clement Johannessen; Ludvig Paul Muren et al. (2004). Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. (ekstern lenke)
• L Thorsen; W Nystad; Olav Dahl et al. (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. (ekstern lenke)
• Mette Pernille Myklebust; Anna Thor; Nina Benedikte Rosenlund et al. (2021). Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study. (ekstern lenke)
• Olav Dahl; Geirfinn Vagstad; Bjarne Magnus Iversen (1996). Cisplatin-based chemotherapy in a renal transplant recipient with metastatic germ cell testicular cancer. (ekstern lenke)
• Torgrim Tandstad; Gabriella Cohn-Cedermark; Olav Dahl et al. (2010). Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. (ekstern lenke)
• Ludvig Muren; Rune Hafslund; Olav Dahl (2000). Partially wedged fields formed by dynamic collimation. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie D Fosså et al. (2005). Blood pressure and body mass index in long-term survivors of testicular cancer. (ekstern lenke)
• J Bernier; J Denekamp; A Rojas et al. (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). (ekstern lenke)
• J. Bernier; J. Denekamp; A. Rojas et al. (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). (ekstern lenke)
• Hans Petter Eikesdal; Baard Christian Schem; Olav Mella et al. (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. (ekstern lenke)
• Ása Karlsdóttir; Ludvig Paul Muren; Tore Wentzel-Larsen et al. (2009). Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. (ekstern lenke)
• Ludvig Paul Muren; Rune Hafslund; Olav Dahl (2000). Partially wedged fields formed by dynamic collimation. (ekstern lenke)
• J Bernier; J Denekamp; M van Glabbeke et al. (1999). ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by EORTC. (ekstern lenke)
• Lise Balteskard; Olav Dahl; Marianne Guren et al. (2011). Faglige anbefalinger for behandling ved analcancer. (ekstern lenke)
• B Glimelius; O Dahl; B Cedermark et al. (2005). Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• Halfdan Sørbye; Dag Jensen; Olav Dahl (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. (ekstern lenke)
• Marianne Brydøy; Jan Oldenburg; J Oldenburg et al. (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. (ekstern lenke)
• Tone Skaali; T Skaali; SD Fossa et al. (2009). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• O Klepp; Olav Dahl; P Flodgren et al. (1997). Risk-adapted treatment of clinical stage I nonseminoma testis cancer. (ekstern lenke)
• Bård Kronen Krossnes; Olav Mella; Olav Dahl (1996). Use of the vasodilator sodium nitroprusside during local hyperthermia: Effects on tumor temperature and tumor response in a rat tumor model. (ekstern lenke)
• Anne Gry Bentzen; Marianne Guren; Barthold Vonen et al. (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. (ekstern lenke)
• Ludvig Paul Muren; Rune Småland; Olav Dahl (2004). Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. (ekstern lenke)
• T Risberg; Erik Lund; E Wist et al. (1995). The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. (ekstern lenke)
• Hege Sagstuen Haugnes; Nina Aass; Sophie D Fosså et al. (2009). Pulmonary Function in Long-Term Survivors of Testicular Cancer. (ekstern lenke)
• C Nord; D Ellingsen; A Mykletun et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• A Karlsdottir; Ludvig Paul Muren; T. Wentzel-Larsen et al. (2006). Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer. (ekstern lenke)
• EK Grov; EK Grov; SD Fossa et al. (2009). The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors. (ekstern lenke)
• Eivind Jullumstrø; Stian Lydersen; Bjørn Møller et al. (2009). Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. (ekstern lenke)
• Sigrid Lunde; Einar Klæboe Kristoffersen; Dipak Sapkota et al. (2016). Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. (ekstern lenke)
• Ása Karlsdóttir; Ludvig Paul Muren; T. Wentzel-Larsen et al. (2008). Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. (ekstern lenke)
• Dirk Rades; Cornelia Setter; Olav Dahl et al. (2012). Fibroblast growth factor 2—A predictor of outcome for patients irradiated for stage II-III non–small-cell lung cancer. (ekstern lenke)
• Olav Dahl; D Kardamakis; B Lind et al. (1996). Clinical assessment of conformal radiotherapy results. (ekstern lenke)
• Christian Falk Dahl; Hege Sagstuen Haugnes; Roy M. Bremnes et al. (2010). A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors. (ekstern lenke)
• Halfdan Sørbye; Olav Dahl (2003). Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to Oxaliplatin combination chemotherapy: Implications for tumor marker monitoring and guidelines. (ekstern lenke)
• hege Sagstuen; N Aass; Sophie D Fosså et al. (2006). Components of the metabolic syndrome in long-term survivors of testicular cancer. (ekstern lenke)
• Olav Dahl; [Mangler fornavn] Fellespubl. (2001). Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. (ekstern lenke)
• Ludvig Muren; Gjertrud Maurstad; Rune Hafslund et al. (2002). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Robert Karlsson; Kristine Engen Andreassen; Wenche Kristiansen et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. (ekstern lenke)
• Mette Pernille Myklebust; Øystein Fluge; Heike Immervoll et al. (2012). Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. (ekstern lenke)
• Ludvig Paul Muren; R Ekerold; Yngve Kvinnsland et al. (2004). On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. (ekstern lenke)
• Luka Stanisavljevic; Jörg Assmus; Kristian Eg Storli et al. (2015). CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer. (ekstern lenke)
• Per Ingvar Øgreid; Aasmund Berner; Olav Dahl et al. (1999). Tissue Prostate-Specific Antigen and Androgen Receptor Immunoreactivity in Prostate Cancer Biopsies before, during and after Neo-Adjuvant Androgen Deprivation Followed by Radiotherapy. (ekstern lenke)
• Jørgen Gitlesen Krohn; Odd R. Monge; Tone Nybø Skorpen et al. (2008). Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. (ekstern lenke)
• Per Øgreid; Sophie D. Fosså; AA Berner et al. (1999). Tissue PSA and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. (ekstern lenke)
• Fredrik Hoel; August Hoel; Ina Katrine Nitschke Pettersen et al. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. (ekstern lenke)
• Ingrid Gurvin Rekeland; Alexander Fosså; Asgeir Lande et al. (2020). Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. (ekstern lenke)
• Sophie D. Fosså; N Aass; K Tveter et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Robert Rutskij; Torfinn Gaarden; R Bremnes et al. (2010). A study of coping in long-term testicular cancer survivors. (ekstern lenke)
• Hans Petter Eikesdal; Baard-Christian Schem; Olav Mella et al. (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. (ekstern lenke)
• Halfdan Sørbye; Øystein Bruserud; Olav Dahl (2001). Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and hemolysis. Case report. (ekstern lenke)
• Ludvig Paul Muren; Rune Hafslund; Harald Valen et al. (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. (ekstern lenke)
• Anna Thor; Mette Pernille Myklebust; Anna Grenabo Bergdahl et al. (2024). miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. (ekstern lenke)
• L Thorsen; W Nystad; H Stigum et al. (2005). The assosiation between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men i general population sample. (ekstern lenke)
• Øystein Fluge; Ove Bruland; Kristin Risa et al. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. (ekstern lenke)
• Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp et al. (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. (ekstern lenke)
• Olav Dahl; J Aarseth; Kjell-Morten Myhr et al. (2004). Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. (ekstern lenke)
• Øystein Fluge; Ingrid Gurvin Rekeland; Katarina Lien et al. (2019). B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. (ekstern lenke)
• Halfdan Sørbye; Dag Jensen; Olav Dahl (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. (ekstern lenke)
• Jens Overgaard; Olav Dahl; Giorgio Arcangeli (2024). ESHO 2-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology. (ekstern lenke)
• Hege Sagstuen Haugnes; Nina Aass; Sophie D Fosså et al. (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. (ekstern lenke)
• Lars Fredrik Fjæra; Daniel J. Indelicato; Kristian Ytre-Hauge et al. (2020). Spatial agreement of brainstem dose distributions depending on biological model in proton therapy for pediatric brain tumors. (ekstern lenke)
• Jens Overgaard; Dionisio Gonzalez-Gonzales; Maarten C.C.H. Hulshof et al. (2009). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. (ekstern lenke)
• Helgi Kjartan Sigurdsson; Jon Arne Søreide; Olav Dahl et al. (2009). Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. (ekstern lenke)
• Torgrim Tandstad; Olof Ståhl; Ulf Håkansson et al. (2014). One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. (ekstern lenke)
• Inger Norderhaug; Olav Dahl; Per Å. Høisæter et al. (2003). Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. (ekstern lenke)
• Jon Espen Dale; Silvia Molinelli; Viviana Vitolo et al. (2019). Optic nerve constraints for carbon ion RT at CNAO ? Reporting and relating outcome to European and Japanese RBE. (ekstern lenke)
• J Overgaard; D Gonzalez Gonzalez; MCCM Hulshof et al. (1995). Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. (ekstern lenke)
• Sophie Dorothea Fosså; Nina Aass; Kjell Tveter et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Alv A Dahl; Marie Østby-Deglum; Jan Oldenburg et al. (2016). Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings. (ekstern lenke)
• Ingrid Gurvin Rekeland; Kari Sørland; Lisbeth Lykke Neteland et al. (2024). Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (ekstern lenke)
• T Tandstad; Olav Dahl; G Cohn-Cedermark et al. (2009). Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program. (ekstern lenke)
• Olav Dahl; Mette Pernille Myklebust; Jon Espen Dale et al. (2020). Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. (ekstern lenke)
• Dirk Rades; Cornelia Setter; Olav Dahl et al. (2012). The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. (ekstern lenke)
• Z Kolitsi; Olav Dahl; Loon R Van et al. (1997). Quality assurance in conformal radiotherapy. DYNARAD consensus report on pratice guidelines. (ekstern lenke)
• L Thorsen; W Nystad; Olav Dahl et al. (2003). The level of physical activity in long-term surdivors of testicular cancer. (ekstern lenke)
• Ivar Sønbø Kristiansen; Inger Norderhaug; Truls Bjerklund Johansen et al. (2003). Brachytherapy for prostatic cancer: a systematic review of clinical and cost effectiveness. (ekstern lenke)
• Ludvig Muren; Gjertrud Maurstad; Rune Hafslund et al. (2001). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Hans Petter Eikesdal; Rolf Bjerkvig; Olav Dahl (2001). Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype. (ekstern lenke)
• Kristine Øverås Aasebø; Jarle Bruun; Christian Holst Bergsland et al. (2022). Prognostic role of tumour infiltrating lymphocytes and macrophages in relation to tumour MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. (ekstern lenke)
• K Bruheim; MG Guren; E Skovlund et al. (2010). Late side effects and quality of life after radiotherapy for rectal cancer. (ekstern lenke)
• Anneke Westermann; Olav Mella; Jacoba Van der Zee et al. (2012). Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. (ekstern lenke)
• Øystein Fluge; Kristin Risa; Sigrid Lunde et al. (2015). B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. (ekstern lenke)
• Harald Arnesen; O Dahl; Trude Aspelin et al. (2003). Sustained Prothrombotic profile after Hip Replacement Surgery. The Influence of Prolonged Prophylaxis with Dalteparin. (ekstern lenke)
• Christian Ekanger; Svein Inge Helle; Lars Anders Rokne Reisæter et al. (2024). Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results from a Prospective Study with 7.2 Years of Follow-Up. (ekstern lenke)
• Halfdan Sørbye; Olav Dahl (2004). Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. (ekstern lenke)
• Anne Gry Bentzen; Marianne Guren; Eva Hoff Wanderås et al. (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. (ekstern lenke)
• Carina Nord; Trine Bjøro; D Ellingsen et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)

Vitenskapelig bokkapittel

• KM Tveit; K-E Giercksky; Olav Dahl (1999). Gastrointestinal kreft. (ekstern lenke)
• KM Tveit; Olav Dahl; Stein O Kvaløy (1999). Behandling med cytostatica. (ekstern lenke)
• Thoralf Christoffersen; Olav Dahl (2007). Legemidler i behandlingen av kreftsykdommer. (ekstern lenke)
• Thoralf Christoffersen; Olav Dahl (2004). Legemidler i behandling av kreftsykdommer. (ekstern lenke)
• Thoralf Christoffersen; Olav Dahl (2004). Legemidler i behandlingen av kreftsykdommer. (ekstern lenke)
• Kjell Magne Tveit; A. Bergan; Olav Dahl et al. (1999). Kolorektalcancer og analcancer. (ekstern lenke)
• F Sigurdsson; D Cunningham; Olav Dahl et al. (1999). Adjuvant chemotherapy for colorectal cancer. (ekstern lenke)
• Olav Dahl; N Aass; T Christoffersen (1999). Bivirkninger. (ekstern lenke)
• Olav Dahl; T Christoffersen; Stein O Kvaløy et al. (1999). Medikamentell kreftbehandling. (ekstern lenke)
• Thoralf Christoffersen; Øystein Fluge; Gustav Lehne et al. (2009). Kreftceller og kjemoterapi. (ekstern lenke)
• Olav Dahl; Stein Kvaløy; Gustav Lehne et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; R Nygaard; Gustav Lehne et al. (2009). Bivirkninger. (ekstern lenke)
• Thoralf Christoffersen; Olav Dahl (2007). Kreftsykdommer. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen (2004). Kreftsykdommer. (ekstern lenke)
• KM Tveit; L Balteskard; Olav Dahl (2009). Gastrointestinal kreft. (ekstern lenke)
• O Klepp; J Norum; Olav Dahl et al. (1999). Testikkelkreft. (ekstern lenke)
• T Christoffersen; Ø Fodstad; EB Smeland et al. (1999). Kreftceller og kjemoterapi. (ekstern lenke)
• Olav Dahl (1995). Interaction of heat and drugs in vitro and in vivo. (ekstern lenke)
• Olav Dahl; W Lilleby; Svein inge Helle et al. (2009). Kreft i nyre, ureter, urinblære og prostata. (ekstern lenke)
• Thoralf Christoffersen; Øystein Fluge; Gustav Lehne et al. (2009). Kreftceller og kjemoterapi. (ekstern lenke)
• Olav Dahl; Randi Nygaard; Thoralf Christoffersen et al. (2009). Bivirkninger. (ekstern lenke)
• Olav Dahl; Stein Olav Kvaløy; Gustav Lehne et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Jens Overgaard (2001). Hyperthermia. (ekstern lenke)
• Olav Dahl (2001). Høyvoltanlegget ved Haukeland Sykehus. (ekstern lenke)
• Olav Dahl; Gustav Lehne (2009). Cancer testis. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen (2004). Kreftsykdommer. (ekstern lenke)
• Olbjørn Klepp; Jan Norum; Olav Dahl et al. (1999). Testikkelkreft. (ekstern lenke)

Konferanseposter

• Baard-Christian Schem; T. Frøystein; B. T. Hjertaker et al. (2001). Regional Hyperthermia as part of trimodality treatment of locally advanced/locally recurrent cervical carcinoma, and primarily inoperable/locally recurrent carcinoma. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie Fosså et al. (2005). Metabolic syndrom in long-term testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie D. Fosså et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• S. Knutsen; Rune Hafslund; Odd R Monge et al. (2001). Dosimetric verification of a dedicated 3-D treatment planning system for episcleral plaque therapy. (ekstern lenke)
• Lise Balteskard; Roy Martin Bremnes; Olav Dahl et al. (2004). Working ability and educational level among long-term survivors of testicular cancer (TCSS) compared to a general population (genPop). (ekstern lenke)
• Marianne Brydøy; Sophie Dorothea Fosså; Olbjørn Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Ludvig Paul Muren; Åsa Karlsdottir; Yngve Kvinnsland et al. (2004). Testing the new ICRU 62 "Planning organ at risk volume" concept for the rectum. (ekstern lenke)
• Åsa Karlsdottir; Dag Clement Johannessen; Ludvig Paul Muren et al. (2004). Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. (ekstern lenke)
• Wenche Kristiansen; Kristine Engen Andreassen; Robert Karlsson et al. (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: A case-parent triad study in a Norwegian-Swedish population. (ekstern lenke)
• Olav Dahl; L. Dæhlin; H. Maartmann-Moe et al. (2001). Improved survival in patients with testicula germ cell tumors. (ekstern lenke)
• Tom Grotmol; Robert Karlsson; Wenche Kristiansen et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes reveals a parent-of-origin effect in SPRY4. (ekstern lenke)
• Wenche Kristiansen; Kristine Engen Andreassen; Robert Karlsson et al. (2013). Genetic variation in AKT1, PTEN, and in the 8q24 locus, and the risk of testicular germ cell tumor. (ekstern lenke)
• Ludvig Muren; Olav Mella; R. Hafslund et al. (2001). National survey of IMRT expectations in Norway. (ekstern lenke)
• Olbjørn Klepp; Olav Dahl; E Cavallin-Stahl et al. (2003). Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). (ekstern lenke)
• Halfdan Sørbye; Bengt Glimelius; Åke Berglund et al. (2003). Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer. (ekstern lenke)
• Robert Karlsson; Wenche Kristiansen; Kristine Engen Andreassen et al. (2012). Validation, fine-mapping, and characterization of six genes related to testicular germ cell tumour in a large Swedish-Norwegian population. (ekstern lenke)

Forskningsrapport

• Truls Bjerklund Johansen; Olav Dahl; Reino Heikilã et al. (2002). Brachyterapy ved prostatakreft. Medisinsk metodevurdering basert på egen litteraturgjennomgang. (ekstern lenke)
• Gustav Lehne; Anders Angelsen; Carl W. Langberg et al. (2011). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av testikkelkreft. (ekstern lenke)
• Gunnar Lind; Olav Dahl; Erik Wist (1998). Erstatningsutvalget for stråleskader. Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86. (ekstern lenke)
• S. Kaasa; L. Vatten; A. Vassenden et al. (2007). Kvalitetsregistre over kreftsykdommer. (ekstern lenke)
• KM Tveit; A. Bergan; Olav Dahl et al. (1999). Kolorektalcancer og analcancer. En veiledning for leger. (ekstern lenke)
• G. Lind; Olav Dahl; E. Wist (1998). Erstatningsutvalget for stråleskader. Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86. (ekstern lenke)
• Sophie D. Fosså; Lars Dæhlin; K Tveter et al. (1994). Maligne tumores i binyre, nyre, ureter, blære og prostata. (ekstern lenke)
• Gunnar Lind; Olav Dahl; Erik Wist (1999). Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86 : rapport/Erstatningsutvalget for stråleskader. (ekstern lenke)

Leserbrev

• Christian Ekanger; Svein Inge Helle; Rune Kvåle et al. (2024). Reply to M. Kamrava and F. Montorsi et al. (ekstern lenke)
• Johannes Jernqvist Gaare; Gonzalo Sanchez Nido; Pawel Szymon Sztromwasser et al. (2018). No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. (ekstern lenke)
• Olav Dahl; Olav Mella (2002). Hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. (ekstern lenke)
• Jørgen Gitlesen Krohn; Olav Dahl (2008). Incidence of iris melanoma in western Norway. (ekstern lenke)
• Jørgen Gitlesen Krohn; Olav Dahl; Tone Nybø et al. (2014). J. Krohn og medarbeidere svarer. (ekstern lenke)
• Jan Oldenburg; Hege Sagstuen Haugnes; Olav Dahl et al. (2015). Behandling ved stadium I-testikkelkreft bør vurderes individuelt. (ekstern lenke)
• Olav Dahl (2005). Clinical hyperthermia combined with radiation is safe. (ekstern lenke)
• Jørgen Gitlesen Krohn; Torbjørn Frøystein; Olav Dahl (2009). Topography of solitary congenital hypertrophy of the retinal pigment epithelium in the ocular fundus. (ekstern lenke)
• Olav Dahl (2008). 2008 ESHO-BSD award winner - Gerard C. van Rhoon. (ekstern lenke)

Fagbok

• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Gustav Lehne; Ingebjørg Baksaas et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. (ekstern lenke)
• Olav Dahl; Gustav Lehne; Thoralf Christoffersen (2016). Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. (ekstern lenke)
• Olav Dahl; Gustav Lehne; Ingebjørg Baksaas et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Mendikamentell kreftbehandling. (ekstern lenke)
• O Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. 6 utgave 1999. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Gustav Lehne; Ingebjørg Baksaas et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Arne Skarstein; Kjell Magne Tveit; A. Bergan et al. (1998). Standardprogram ved colorectalcancer. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Gustav Lehne; Ingebjørg Baksaas et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. (ekstern lenke)

Doktorgradsavhandling

• Olav Dahl (1983). Experimental hypothermia in a neurogenic rat tumour : combi- nation with cytotoxic drugs. (ekstern lenke)
• Luka Stanisavljevic; Olav Dahl (2016). Molecular and clinicopathological factors with emphasis on prognostic and predictive factors for survival. (ekstern lenke)
• Havjin Jacob; Olav Dahl (2018). Prognostic biomarkers in stage II and III colorectal cancer: A study with focus on microRNAs and S100A4. (ekstern lenke)
• Annette Larsen; Olav Dahl (2007). Inflammatory biomarkers with focus on Calprotectin (S100A8/S100A9) and S100A12 (EN-RAGE) : method development and application in acute radiation proctitis and rheumatoid arthritis patients. (ekstern lenke)
• Nils Hovdenak; Olav Dahl (2004). Acute radiation proctitis: a clinical, histopathological and histochemical study. (ekstern lenke)

Konferanseforedrag

• Olav Dahl (2005). Får pasienter med lokalisert prostatakreft adekvat tilbud om radikal strålebehandling?. (ekstern lenke)
• Bengt Glimelius; B. Cedermark; Olav Dahl et al. (2003). Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• Marianne Brydøy; S Fossa; Olbjørn Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Jørgen Gitlesen Krohn; Torbjørn Frøystein; Olav Dahl (2006). Posterior uveal melanoma. Distribution of initiation sites and patterns of tumour extent in the ocular fundus. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie D Fosså et al. (2004). Blood pressure and Body mass index in testicular cancer survivors. (ekstern lenke)
• Ludvig Muren; Gjertrud Maurstad; Rune Hafslund et al. (2001). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Olav Dahl (2006). The present conditions and the future prospects of clinical test of hyperthermia in Europe. (ekstern lenke)
• Marianne Brydøy; S. Fossa; O. Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie D. Fosså et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Anneke M. Westermann; Ellen Jones; Baard-Christian Schem et al. (2003). Regional hyperthermia added to chemoradiotherapy in advanced cervical cancer: Multicenter international feasibility. (ekstern lenke)
• Ludvig Paul Muren; Anthony Thomas Redpath; D Mclaren et al. (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy. (ekstern lenke)
• S Knutsen; Rune Hafslund; Odd R Monge et al. (2001). Verification of a 3-D treatment planning system for episcleral brachytherapy. (ekstern lenke)
• Marianne Brydøy; Sophie D. Fosså; Roy Bremnes et al. (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. (ekstern lenke)
• Olav Dahl; Kjell Magne Tveit; Erik Carlsen et al. (2003). Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study. (ekstern lenke)
• Åsa Karlsdottir; Ludvig Paul Muren; Tore Wentzel-Larsen et al. (2004). Dose response in a series of 495 patients with early prostate cancer. (ekstern lenke)
• Ludvig Paul Muren; Åsa Karlsdottir; Yngve Kvinnsland et al. (2004). A test of the ICRU 62 "Planning organ at Risk Volume" concept for the rectum. (ekstern lenke)
• Yngve Kvinnsland; Ludvig Paul Muren; Olav Dahl (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of the equivalent uniform doses and the volume parameter. (ekstern lenke)
• Bengt Glimelius; Halfdan Sørbye; L Balteskard et al. (2005). A randomised phase III multicenter trial comparing irinotecan in combination with 5FU and folinic acid (FU/FA) given according to the Nordic bolus schedule to irinotecan in combination with 5FU/FA given according to the bolus/infused de Gramont schedule, in patients with metastatic colorectal cancer. (ekstern lenke)
• Torgrim Tandstad; E. Stahl; Olav Dahl et al. (2014). Management of clinical stage I seminomatous testicular cancer: A report from SWENOTECA. (ekstern lenke)

Konferanseabstrakt

• T Skaali; SD Fossa; Roy M. Bremnes et al. (2007). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen; N Aass; Sophie D Fosså et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Ludvig Paul Muren; R Ekerold; Rune Småland et al. (2003). Treatment precision and treatment effect in conformal radiotherapy of urinary bladder cancer - preliminary results. (ekstern lenke)
• Marianne Brydøy; S Fossa; Olbjørn Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Sophie D Fosså et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Ludvig Paul Muren; Åsa Karlsdottir; Yngve Kvinnsland et al. (2004). Testing the new ICRU 62 'planning organ at risk volume' concept for the rectum. (ekstern lenke)
• Marianne Brydøy; j oldenburg; Olbjørn Klepp et al. (2006). Self-reported paresthesia, Raynaud,s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Helgi Kjartan Sigurdsson; Hartwig Kørner; Olav Dahl et al. (2008). Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. (ekstern lenke)
• Torgrim Tandstad; Arne Solberg; Ulf Håkansson et al. (2012). Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma. (ekstern lenke)
• Marianne Brydøy; Johannes Oldenburg; Olbjørn Klepp et al. (2006). Self-reported paresthesias, Raynaud's phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TG) survivors. (ekstern lenke)
• Marianne Brydøy; SS Fosså; Roy M. Bremnes et al. (2005). Self-reported paresthesia, Raynaud’s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Olbjørn Klepp; Olav Dahl; E Cavallin-Stahl et al. (2003). Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). (ekstern lenke)
• Einar Waldeland; Olav Dahl; Odd Harald Odland et al. (2014). Particle therapy in Norway - report from the national project group. (ekstern lenke)
• Jørgen Gitlesen Krohn; Torbjørn Frøystein; Olav Dahl (2008). Topographical distribution of posterior uveal melanoma, choroidal nevi, and congenital hypertrophy of the retinal pigment epithelium. (ekstern lenke)
• Roy M. Bremnes; hege Sagstuen; N Aass et al. (2006). Cardiovascular (CV)morbidity and predicted mortality in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Tom Grotmol; Robert Karlsson; Wenche Kristiansen et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in the tumor suppressor gene SPRY4. (ekstern lenke)
• Hege Sagstuen; Nina Aass; Nina Kathrine Aass et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Marianne Brydøy; Sophie D. Fosså; Roy Bremnes et al. (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. (ekstern lenke)
• Sven-Erik Olofsson; Olav Dahl; Mats Jerkeman et al. (2009). Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA. (ekstern lenke)
• Roy M. Bremnes; Ellen Karine Grov; O Klepp et al. (2007). Is neuroticism associated with long-term morbidity in testicular cancer survivors?. (ekstern lenke)
• L Balteskard; Roy M. Bremnes; O Dahl et al. (2004). Working ability and educational level among long-term survivors of teasticular cancer (TCSS) compared to a general population (GenPop). (ekstern lenke)
• Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Hege Sagstuen Haugnes; Nina Aass; Sophie D Fosså et al. (2008). Pulmonary function in long-term testicular cancer survivors. (ekstern lenke)
• Tom Grotmol; Robert Karlsson; Wenche Kristiansen et al. (2014). Scandinavian studies of gene variants and risk of testicular germ cell tumor. (ekstern lenke)

Lærebok

• O Dahl; Thoralf Christoffersen; Stein Kvaløy (1999). Cytostatika. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein O Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling [6. utg.]. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Olav Dahl; Thoralf Christoffersen; Stein Kvaløy et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)

Fagartikkel

• Steinar Skrede; Olav Dahl (2017). Hybrid mellom søstermarihand Dactylorhiza sambucina og skogmarihand Dactylorhiza maculata subsp. fuchsii i Telemark.. (ekstern lenke)

Kapittel i fagbok

• Olav Dahl; Randi Nygaard; Marianne Brydøy et al. (2016). Bivirkninger. (ekstern lenke)
• Olav Dahl; Stein Olav Kvaløy; Gustav Lehne et al. (2016). Medikamentell kreftbehandling. (ekstern lenke)
• Thoralf Christoffersen; Øystein Bruserud; Øystein Fluge et al. (2016). Kreftbiologi og medikamentell terapi. (ekstern lenke)

Lederartikkel

• Olav Dahl (2005). First things first. (ekstern lenke)
• Olav Dahl; Frank Pfeffer (2015). Twenty-five years with adjuvant chemotherapy for colon cancer--a continuous evolving concept.. (ekstern lenke)
• Olav Dahl (2009). Follow up your unexpected clinical observations!. (ekstern lenke)
• Olav Dahl; Marianne Brydøy (2012). Testicular germ cell tumours - still many challenges. (ekstern lenke)
• Olav Dahl (2022). Watch your steps, especially when changing treatment for locally advanced rectal cancer. (ekstern lenke)
• Olav Dahl; Marianne Brydøy (2019). The pioneers behind immune checkpoint blockers awarded the Nobel Prize in physiology or medicine 2018. (ekstern lenke)
• Olav Dahl (2005). Protons. A step forward or perhaps only more expensive radiation therapy?. (ekstern lenke)

Fremhevet artikkel i media

• Olav Dahl (1998). Arbiter. (ekstern lenke)
• Olav Dahl (1998). Current Controversies in Cancer. Should systematic lymph node dissection be recommended for gastric cancer?. (ekstern lenke)
• Olav Dahl (1998). Greetings from the president of the International Association for Hyperthermic Oncology. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Olav Dahl; Øystein Fluge (2008). Analkreft. (ekstern lenke)
• Thoralf Christoffersen; Tormod K. Guren; Karen-Lise Garm Spindler et al. (2009). Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. (ekstern lenke)
• Ludvig Paul Muren; Rune Småland; Olav Dahl (2004). Conformal radiotherapy of urinary bladder cancer. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin